Médecins pour Cancer de la langue à l'étranger — Page 3

Spécialisé dans les thérapies ciblées contre le cancer et l'immunothérapie – le Dr Mutlu apporte des approches avancées au traitement du cancer de la langue au Medical Park Antalya.

• Formé en oncologie médicale à l'université d'Akdeniz et aux États-Unis
• Expert en recherche génétique de nouvelle génération pour le traitement personnalisé du cancer
• Professeur agrégé possédant une vaste expérience des protocoles de chimiothérapie
• Travaille au complexe hospitalier Medical Park Antalya – un centre d'oncologie de premier plan

Le Dr Alemdar est spécialisé en oncologie médicale, avec un accent particulier sur le cancer de la langue, grâce à une formation approfondie à l'Université Akdeniz.

• Certifié en oncologie médicale depuis 2018
• Plus de 15 ans d'expérience en oncologie et en médecine interne
• Exerce au complexe hospitalier Medical Park Antalya

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Le Dr Erkan Karatas est hautement qualifié en oto-rhino-laryngologie et en chirurgie de la tête et du cou, avec une vaste expérience internationale dans des institutions prestigieuses.

• Se spécialiser en chirurgie de la tête et du cou dans plusieurs centres de premier plan en Europe et aux États-Unis
• Se former à la faculté de médecine de Hanovre et dans d'autres institutions de premier plan
• Être membre de plusieurs associations internationales d'oto-rhino-laryngologie et de chirurgie de la tête et du cou

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

La professeure Elke Jaeger réalise 1 100 interventions par an – l'une des meilleures oncologues d'Allemagne selon le classement Focus depuis 20 ans.

• Plus de 38 ans de spécialisation en oncologie et hématologie
• Chef du service d'oncologie et d'hématologie à la clinique Nordwest
• Professeure en oncologie interdisciplinaire à l'université Goethe
• Spécialiste de premier plan des sarcomes avec un volume de cas élevé

Le Dr Topcu a été formé dans des centres d'oncologie prestigieux tels que MD Anderson et Sunnybrook Odette, se spécialisant dans les cancers de la tête et du cou, y compris le cancer de la langue.

• Internat en oncologie médicale à l'Université Technique de Karadeniz
• Membre de l'ESMO et de l'ASCO – principales sociétés mondiales d'oncologie
• Traiter un large éventail de cancers, avec une spécialisation dans les cas complexes
• Travailler à l'Hôpital Universitaire Biruni au sein d'équipes multidisciplinaires

Spécialisé en radio-oncologie à l'Université de Marmara – le Dr Sahibov se concentre sur la planification précise du traitement du cancer de la langue.

• Formé à la Faculté de Médecine de l'Université de Marmara
• Spécialisation en radio-oncologie achevée en 2016
• Travailler à l'Hôpital Emsey avec un équipement de radiothérapie de pointe

Le Dr Shruti Kate est une oncologue de premier plan, experte dans le traitement du cancer de la langue, formée par des leaders de l'oncologie au Tata Memorial Hospital.

• Se spécialiser dans les tumeurs solides, y compris les cancers de la tête et du cou
• Être expert en immunothérapie et en thérapie métronomique pour les cancers avancés
• Présenter des recherches lors de la Conférence mondiale sur le cancer du poumon
• Être membre de l'ASCO, de l'ESMO et d'autres sociétés d'oncologie de premier plan